Confirmation that variants in TTI2 are responsible for autosomal recessive intellectual disability.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
10 2019
Historique:
received: 07 05 2019
revised: 21 06 2019
accepted: 30 06 2019
pubmed: 11 7 2019
medline: 4 9 2020
entrez: 11 7 2019
Statut: ppublish

Résumé

TTI2 (MIM 614126) has been described as responsible for autosomal recessive intellectual disability (ID; MRT39, MIM:615541) in only two inbred families. Here, we give an account of two individuals from two unrelated outbred families harbouring compound heterozygous TTI2 pathogenic variants. Together with severe ID, progressive microcephaly, scoliosis and sleeping disorder are the most striking features in the two individuals concerned. TTI2, together with TTI1 and TELO2, encode proteins that constitute the triple T heterotrimeric complex. This TTT complex interacts with the HSP90 and R2TP to form a super-complex that has a chaperone function stabilising and maturing a number of kinases, such as ataxia-telangiectasia mutated and mechanistic target of rapamycin, which are key regulators of cell proliferation and genome maintenance. Pathogenic variants in TTI2 logically result in a phenotype close to that caused by TELO2 variants.

Identifiants

pubmed: 31290144
doi: 10.1111/cge.13603
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
TTI2 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

354-358

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil. 2011;32(2):419-436. https://doi.org/10.1016/j.ridd.2010.12.018.
Global Research on Developmental Disabilities Collaborators. Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Glob Health. 2018;6(10):e1100.#x2010;e1121. https://doi.org/10.1016/S2214-109X(18)30309-7.
Wieczorek D. Autosomal dominant intellectual disability. Med Genet. 2018;30(3):318-322. https://doi.org/10.1007/s11825-018-0206-2.
Gilissen C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511(7509):344-347. https://doi.org/10.1038/nature13394.
Jamra R. Genetics of autosomal recessive intellectual disability. Med Genet. 2018;30(3):323-327. https://doi.org/10.1007/s11825-018-0209-z.
Kahrizi K, Hu H, Hosseini M, et al. Effect of inbreeding on intellectual disability revisited by trio sequencing. Clin Genet. 2019;95(1):151-159. https://doi.org/10.1111/cge.13463.
Martin HC, Jones WD, McIntyre R, et al. Quantifying the contribution of recessive coding variation to developmental disorders. Science. 2018;362(6419):1161-1164. https://doi.org/10.1126/science.aar6731.
Najmabadi H, Hu H, Garshasbi M, et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature. 2011;478(7367):57-63. https://doi.org/10.1038/nature10423.
Langouët M, Saadi A, Rieunier G, et al. Mutation in TTI2 reveals a role for triple T complex in human brain development. Hum Mutat. 2013;34(11):1472-1476. https://doi.org/10.1002/humu.22399.
Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18(7):696-704. https://doi.org/10.1038/gim.2015.148.
Rao AR, Nelson SF. Calculating the statistical significance of rare variants causal for Mendelian and complex disorders. BMC Med Genomics. 2018;11(1):53. https://doi.org/10.1186/s12920-018-0371-9.
Takai H, Xie Y, de Lange T, Pavletich NP. Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes. Genes Dev. 2010;24(18):2019-2030. https://doi.org/10.1101/gad.1956410.
Sugimoto K. Branching the Tel2 pathway for exact fit on phosphatidylinositol 3-kinase-related kinases. Curr Genet. 2018;64(5):965-970. https://doi.org/10.1007/s00294-018-0817-9.
You J, Sobreira NL, Gable DL, et al. A syndromic intellectual disability disorder caused by variants in TELO2, a gene encoding a component of the TTT complex. Am J Hum Genet. 2016;98(5):909-918. https://doi.org/10.1016/j.ajhg.2016.03.014.
Barlow C, Hirotsune S, Paylor R, et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 1996;86(1):159-171.

Auteurs

Alban Ziegler (A)

Département de Biochimie et Génétique du CHU d'Angers, Centre Hospitalier Universitaire d'Angers, Angers, France.
Mitolab, UMR INSERM 1083-CNRS 6015, Université d'Angers, Angers, France.

Patricia Bader (P)

Department of Genetics, Carle Clinics, Urbana, Illinois.

Kirsty McWalter (K)

Exome Sequencing Program, GeneDx, Gaithersburg, Maryland.

Ganka Douglas (G)

Exome Sequencing Program, GeneDx, Gaithersburg, Maryland.

Clara Houdayer (C)

Département de Biochimie et Génétique du CHU d'Angers, Centre Hospitalier Universitaire d'Angers, Angers, France.

Céline Bris (C)

Département de Biochimie et Génétique du CHU d'Angers, Centre Hospitalier Universitaire d'Angers, Angers, France.

Stephanie Rouleau (S)

Service d'Endocrinologie Pédiatrique, Centre Hospitalier Universitaire d'Angers, Angers, France.

Régis Coutant (R)

Service d'Endocrinologie Pédiatrique, Centre Hospitalier Universitaire d'Angers, Angers, France.

Estelle Colin (E)

Département de Biochimie et Génétique du CHU d'Angers, Centre Hospitalier Universitaire d'Angers, Angers, France.
Mitolab, UMR INSERM 1083-CNRS 6015, Université d'Angers, Angers, France.

Dominique Bonneau (D)

Département de Biochimie et Génétique du CHU d'Angers, Centre Hospitalier Universitaire d'Angers, Angers, France.
Mitolab, UMR INSERM 1083-CNRS 6015, Université d'Angers, Angers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH